Mapping the immune system could lead to the creation of drugs that help our bodies win the fight against cancer and other diseases. That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotech company that’s using cutting-edge genomics & ML technology to map the human immune system Read article >
The post Immunai Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs appeared first on NVIDIA Blog.
- View Press Release
- Visit NVIDIA Corporation